EUVIMEDEUVIMED entdecken
Open Access

How I treat non-transfusion-dependent β-thalassemia

Antoine N Saliba iD, Khaled M Musallam iD, Ali T Taher iD

Blood · 2023

DOI: 10.1182/blood.2023020683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Antoine N Saliba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: beta-Thalassemia, Thalassemia, Iron Overload. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intricate interplay of anemia and iron overload under the pathophysiological umbrella of ineffective erythropoiesis in non-transfusion-dependent β-thalassemia (NTDT) results in a complex variety of clinical phenotypes that are challenging to diagnose and manage. In this article, we use a clinical framework rooted in pathophysiology to present 4 common scenarios of patients with NTDT. Starting from practical considerations in the diagnosis of NTDT, we delineate our strategy for the longitudinal care of patients who exhibit different constellations of symptoms and complications. We highlight the use of transfusion therapy and novel agents, such as luspatercept, in the patient with anemia-related complications. We also describe our approach to chelation therapy in the patient with iron overload. Although tackling every specific complication of NTDT is beyond the scope of this article, we touch on the management of the various morbidities and multisystem manifestations of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaThalassemiaIron OverloadHumansIron Chelating AgentsChelation Therapy

Substanzen

Iron Chelating Agents

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, MN.
  • Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Antoine N Saliba, Khaled M Musallam, Ali T Taher

Zitieren

APA

Saliba, A. N., Musallam, K. M., & Taher, A. T. (2023). How I treat non-transfusion-dependent β-thalassemia. Blood. https://doi.org/10.1182/blood.2023020683

Vancouver

Saliba AN, Musallam KM, Taher AT. How I treat non-transfusion-dependent β-thalassemia. Blood. 2023. doi:10.1182/blood.2023020683

BibTeX
@article{Saliba2023,
  author = {Saliba, Antoine N and Musallam, Khaled M and Taher, Ali T},
  title = {How I treat non-transfusion-dependent β-thalassemia},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2023020683}
}
Kostenlos starten →